A team led by researchers from Mass General Brigham reports promising results for a monoclonal antibody that takes aim at a new target for Alzheimer’s disease.
Arrakis CEO cites ‘cul-de-sacs’ on road to RNA-intercepting cancer drugs
Five years ago, a small startup led by biotech veteran Michael Gilman announced progress against a cancer gene that had bedeviled drug developers for 40